Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Adalimumab for the treatment of Crohn's disease
Konstantinos A. Papadakis
Gastroenterology and Hepatology
Research output
:
Contribution to journal
›
Article
›
peer-review
7
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Adalimumab for the treatment of Crohn's disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Adalimumab
100%
Crohn Disease
75%
human TNF protein
27%
Infliximab
23%
Biological Factors
21%
Intestines
17%
Rheumatoid Arthritis
16%
Colon
15%
Monoclonal Antibodies
14%
Tumor Necrosis Factor-alpha
14%
Therapeutics
12%
Inflammation
11%
Safety
11%